Humans with function-disrupting variants in the myostatin gene (MSTN) have increased skeletal muscle mass and strength, and less adiposity

J Joseph L. Herman P Peter Dornbos K Karl Landheer B Benjamin J. Geraghty M Marc A. Egerman D Duc Phan M Mary Germino J Jason W. Mastaitis J Johnathon R. Walls L Luca A. Lotta G Gonçalo Abecasis A Aris Baras J Judith Y. Altarejos M Mark W. Sleeman O Olle Melander T Tea Shavlakadze (Regeneron Pharmaceuticals) G George D. Yancopoulos (Regeneron Pharmaceuticals, Tarrytown, NY) J Jonas Bovijn J Jonathan Marchini D David J. Glass

Article Details

Volume / Issue Vol. 17, Issue 1
Published March 13, 2026
ISSN 2041-1723
Publisher Nature Portfolio

Journal Info

Nature Communications

Nature Portfolio

ISSN: 2041-1723 Open Access Life Sciences

Authors (20)

J

Joseph L. Herman

P

Peter Dornbos

K

Karl Landheer

B

Benjamin J. Geraghty

M

Marc A. Egerman

D

Duc Phan

M

Mary Germino

J

Jason W. Mastaitis

J

Johnathon R. Walls

L

Luca A. Lotta

G

Gonçalo Abecasis

A

Aris Baras

J

Judith Y. Altarejos

M

Mark W. Sleeman

O

Olle Melander

T

Tea Shavlakadze

Regeneron Pharmaceuticals

G

George D. Yancopoulos

Regeneron Pharmaceuticals, Tarrytown, NY

J

Jonas Bovijn

J

Jonathan Marchini

D

David J. Glass